Credit Suisse Reiterates Neutral, Raises PT On Pharmacyclics As Deal Looks Likely To Happen
March 06, 2015 at 08:45 AM EST
In a report published Friday, Credit Suisse analyst Jason Kantor reiterated a Neutral rating on Pharmacyclics, Inc. (NASDAQ: PCYC), and ...